Brief: FDA Says Received Reports Describing Serious Adverse Events When Renuvion/J-Plasma Device Was Used Directly On Skin

Apyx Medical

14/03/2022 15:06

March 14 (Reuters) - U.S. FDA:
    * U.S. FDA SAYS IT HAS RECEIVED REPORTS DESCRIBING SERIOUS ADVERSE EVENTS
WHEN
APYX MEDICAL'S RENUVION/J-PLASMA DEVICE WAS USED DIRECTLY ON THE SKIN
    * U.S. FDA - RECEIVED REPORTS DESCRIBING POTENTIALLY LIFE-THREATENING
ADVERSE
EVENTS WHEN THE RENUVION/J-PLASMA DEVICE WAS USED UNDER THE SKIN


Further company coverage:  APYX.O 

 ((Reuters.Briefs@thomsonreuters.com;))